tirzepatide cas no Tirzepatide, CasNo.2023788-19-2 Hangzhou J&H Chemical Co., Ltd. China (Mainland) Tirzepatide 2mg/5mg/10mg/15mg/30mg Cas No.: 2023788-19-2

Global obesity spending reached nearly $24bn in 2023, an over sevenfold growth in value in just three years, driven by the advent of new agents, and from 2024 onwards the market is forecasted to accelerate rapidly, with a possible 24-27% CAGR to 2028, and a potential value of up to $131bn by 2028, according to the IQVIA Institutes Global Use of Medicines 2024 report 4

To support yourself: Keep workouts shorter if needed Prioritize strength over intensity Add electrolytes if you sweat regularly Eat a small protein-rich snack before exercise if tolerated Hydration and Electrolytes: An Important Part of Exercising on Semaglutide Semaglutide can reduce thirst, so dehydration is a hidden risk

I started on a lower dose and gradually moved up

While she wishes the drugs werent as popular as they are, shes accepted theyre here to stay